BioCentury | Jan 9, 2021
Translation in Brief
Fusing camelid antibodies to toxin derivatives to treat botulism; plus BioNTech applies platform to multiple sclerosis, a molecule that stops axon degeneration and more
...fused to BoNT derivatives shortened the duration of muscle paralysis and increased survival in mice. Wake Forest...
...December.TARGETSSARM1 – Sterile alpha and TIR motif containing 1 Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Boston Children's Hospital Wake Forest University New...
...December.TARGETSSARM1 – Sterile alpha and TIR motif containing 1 Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Boston Children's Hospital Wake Forest University New...